GGrantIndex
← Leaderboards

Norman L Foster

University Of Michigan At Ann Arbor

$9,519,683
Attributed
$10,394,571
Total exposure
10
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200524
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24

Funding mix

By agency

NIH$10,394,571 · 10

By mechanism

P50$3,357,816 · 2
R44$2,939,795 · 1
R01$2,384,705 · 1
R42$1,582,473 · 1
R41$125,477 · 1
M01$4,305 · 4

Top collaborators

Most similar at University Of Michigan At Ann Arbor

Same institution · by research overlap

Others in their field

Top investigators on “Dementia

Research focus

DementiaAlzheimer&AposClinical ResearchS DiseaseElderlyHuman SubjectAlzheimer'S DiseaseImagePositron Emission TomographyCaregiversCollaborationsLongitudinal Human StudyComputer SoftwareCostCommercializationAmericanPrototypeQuality Of CareNeuropsychological TestsCognitivePathologic ProcessInterestCaringMemory

Grant awards (31)

CUSTOMIZABLE TRAINING SOFTWARE FOR PROFESSIONAL ALZHEIMER DIRECT CARE PROVIDERS$1,203,762
R44 · FY2024 · AG · contact PI
CUSTOMIZABLE TRAINING SOFTWARE FOR PROFESSIONAL ALZHEIMER DIRECT CARE PROVIDERS$1,279,718
R44 · FY2023 · AG · contact PI
CUSTOMIZABLE TRAINING SOFTWARE FOR PROFESSIONAL ALZHEIMER DIRECT CARE PROVIDERS$456,315
R44 · FY2022 · AG · contact PI
Memory Care Partner$714,336
R42 · FY2017 · AG · contact PI
Memory Care Partner$134,022
R42 · FY2017 · AG · contact PI
Memory Care Partner$734,115
R42 · FY2016 · AG · contact PI
The Memory Care Navigator: A Proactive Guide$125,477
R41 · FY2012 · AG · contact PI
CORE--CLINICAL CORE$546,453
P50 · FY2009 · AG · contact PI
PREDICTING INDIVIDUAL PROGRESSION IN ALZHEIMER'S DISEASE$232,397
P50 · FY2009 · AG · contact PI
CORE--CLINICAL CORE$531,447
P50 · FY2008 · AG · contact PI
PREDICTING INDIVIDUAL PROGRESSION IN ALZHEIMER'S DISEASE$226,578
P50 · FY2008 · AG · contact PI
CORE--CLINICAL CORE$526,740
P50 · FY2007 · AG · contact PI
PREDICTING INDIVIDUAL PROGRESSION IN ALZHEIMER'S DISEASE$225,144
P50 · FY2007 · AG · contact PI
CORE--CLINICAL CORE$300,311
P50 · FY2006 · AG · contact PI
PREDICTING INDIVIDUAL PROGRESSION IN ALZHEIMER'S DISEASE$128,695
P50 · FY2006 · AG · contact PI
MICHIGAN ALZHEIMER?S DISEASE RESEARCH CENTER D(LONGITUDINAL COHORT) D MINORITY S$1,533
M01 · FY2006 · RR · contact PI
Pilot Collaborative PET Imaging Trial$723,965
R01 · FY2005 · AG
CORE--CLINICAL CORE$291,564
P50 · FY2005 · AG
PREDICTING INDIVIDUAL PROGRESSION IN ALZHEIMER'S DISEASE$125,000
P50 · FY2005 · AG
MICHIGAN ALZHEIMER?S DISEASE RESEARCH CENTER D(LONGITUDINAL COHORT) D MINORITY$2,058
M01 · FY2005 · RR
Pilot Collaborative PET Imaging Trial$765,045
R01 · FY2004 · AG
Michigan Alzheimer's Disease Research Center (Longitudinal Cohort)$508
M01 · FY2004 · RR
Pilot Collaborative PET Imaging Trial$895,695
R01 · FY2003 · AG
CORE--CLINICAL$0
P50 · FY2002 · AG
CORE--CLINICAL$0
P50 · FY2002 · AG
Apolipoprotein E &presenilin-1 testing in Alzheimer's disease$0
M01 · FY2002 · RR
CORE--CLINICAL$0
P50 · FY2001 · AG
CORE--CLINICAL$0
P50 · FY2001 · AG
CORE--CLINICAL$223,487
P50 · FY2000 · AG
NEUROPHARMACOLOGIC CHALLENGES IN DEMENTIA$206
M01 · FY2000 · RR
Apolipoprotein E &presenilin-1 testing in Alzheimer's disease$0
M01 · FY2000 · RR